OT Pharma Fund VII, LLC is a private investment fund based in Boston, Massachusetts. According to its most recent Form D, filed Nov 5, 2021, it has sold $9,429,968 of interests to 32 investors since its first sale in Oct 2021. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Richard Thoms; LLC OT Management; LLC Assure Fund Management II.
- Total raised
- $9,429,968Cumulative sales reported on Form D
- Investors
- 32
- First sale
- Oct 14, 2021
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Richard Thoms; LLC OT Management; LLC Assure Fund Management II
- Latest Form D
- Nov 5, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Nov 5, 2021 | Form D/A (amendment) | $9,429,968 | 32 | SEC.gov ↗ |
| Oct 15, 2021 | Form D | $4,627,587 | 26 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Oct 15, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about OT Pharma Fund VII, LLC
What is the minimum investment for OT Pharma Fund VII, LLC?
According to its latest Form D, filed Nov 5, 2021, the minimum investment OT Pharma Fund VII, LLC accepts from an outside investor is $100,000.
Who can invest in OT Pharma Fund VII, LLC?
OT Pharma Fund VII, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has OT Pharma Fund VII, LLC raised?
OT Pharma Fund VII, LLC reports $9,429,968 sold from 32 investors on its Form D filed Nov 5, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is OT Pharma Fund VII, LLC based?
OT Pharma Fund VII, LLC is based in Boston, Massachusetts.
When did OT Pharma Fund VII, LLC launch?
OT Pharma Fund VII, LLC reports its first sale in Oct 2021.
Size compared with every private investment fund
Raised more than 40% of the 538 private investment funds based in Massachusetts, and more than 40% of all 10,324 that report sales.
Other funds with the same team
More private investment funds in Boston
- Acadian U.S. Micro/Small-Cap Equity Portable Alpha Fund, LLC$1.7M
- NHIT: Core Plus Fixed Income Trust$4.2B
- Bain Capital Senior Loan Fund, L.P.$3.3B
- Acadian U.S. Managed Volatility Equity Fund, LLC$91.7M
- Acadian Emerging Markets Small-Cap Equity Fund, LLC$2.3B
- Acadian Emerging Markets Managed Volatility Equity Fund, LLC$664M